Catalyst Funds Management’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
CCM
PFCS
GCGM
DMC
MC
MCM
Catalyst Funds Management's GUTS Position: Q2 2026 in Review
Catalyst Funds Management reduced its Fractyl Health (GUTS) stake by 73% in Q2 2026, selling an estimated $24.3K and leaving 12,725 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #642.
Catalyst Funds Management first reported a position in GUTS in Q2 2025 and has held it in 3 quarters since. The position peaked at $25.6K in Q2 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.
- Catalyst Funds Management held 12,725 shares of Fractyl Health worth $10.1K as of Q2 2026.
- Catalyst Funds Management sold 34,075 Fractyl Health shares in Q2 2026, an estimated $24.3K.
- Fractyl Health made up ﹤0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #642 holding.
- Catalyst Funds Management first reported a position in Fractyl Health in Q2 2025 and has held it in 3 quarters since.
- Catalyst Funds Management's Fractyl Health position peaked at $25.6K in Q2 2025.
- 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.
Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.